or Try an Advanced Search...

    Endocrine Disorders Stocks List

    Symbol Grade Name % Change
    VKTX B Viking Therapeutics, Inc. 1.61
    PFE D Pfizer, Inc. 1.26
    ENZ F Enzo Biochem, Inc. 2.88
    SPRB F Spruce Biosciences, Inc. 1.32
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Cancer Diabetes Disease Medication Medicine Metabolic Disease Obesity Acid Alcohol Alzheimer's Disease Anemia Animal Health Anti Infectives Antibodies Autoimmune Disease Biochemistry Biology Biotechnology Cachexia

    Related ETFs - A few ETFs which own one or more of the above listed Endocrine Disorders stocks.

    Symbol Grade Name Weight
    HDLB C ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 13.4
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 7.84
    FDL A First Trust Morningstar ETF 7.32
    ULTY B Tidal Trust II YieldMax Ultra Option Income Strategy ETF 5.68
    PJP A PowerShares Dynamic Pharmaceuticals 5.5
    View all Endocrine Disorders ETFs...
    Compare ETFs
    Compare FDL to ULTY Compare FTXH to PJP Compare HDLB to PJP

        Endocrine Disorders Stocks Recent News

        Date Stock Title
        May 6 PFE Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
        May 6 PFE Pfizer hires Citi healthcare analyst Baum to lead strategy and innovation
        May 6 VKTX Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 72% of the company
        May 6 PFE Pfizer: Ignore The Dead Cat Bounce
        May 6 PFE BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
        May 6 PFE UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
        May 6 PFE BioNTech says 90% of 2024 revenues will accrue at end of year
        May 6 PFE Pfizer Announces New Chief Strategy and Innovation Officer
        May 5 PFE 3 No-Brainer Stocks to Buy in May
        May 4 PFE Pharma R&D productivity seen improving for the first time in years - Deloitte
        May 4 PFE Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
        May 4 PFE Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
        May 4 PFE 3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
        May 3 PFE Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
        May 3 PFE Vanguard Health Care Fund's Strategic Moves in Q1 2024: A Focus on Pfizer Inc
        May 3 PFE Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
        May 3 PFE Here's Why Pfizer (PFE) is a Strong Momentum Stock
        May 3 PFE Q1 2024 Cardiff Oncology Inc Earnings Call
        May 3 PFE NHS to provide Pfizer’s Voxelotor to treat sickle cell disease
        May 2 PFE Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Cancer Diabetes Disease Medication Medicine Metabolic Disease Obesity Acid Alcohol Alzheimer's Disease Anemia Animal Health Anti Infectives Antibodies Autoimmune Disease Biochemistry Biology Biotechnology Cachexia
        Endocrine Disorders

        Endocrine disorders are medical conditions that affect the endocrine system, which is a network of glands that produce hormones that regulate many bodily functions, including metabolism, growth and development, and sexual function. Common endocrine disorders include diabetes, thyroid disease, and adrenal gland disorders.

        Browse All Tags